Gateway Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,512
Closed -$248K 480
2025
Q1
$248K Sell
3,512
-1,003
-22% -$70.9K ﹤0.01% 463
2024
Q4
$297K Buy
4,515
+66
+1% +$4.34K ﹤0.01% 441
2024
Q3
$313K Sell
4,449
-8,222
-65% -$578K ﹤0.01% 444
2024
Q2
$1.04M Sell
12,671
-8,649
-41% -$712K 0.01% 315
2024
Q1
$1.86M Buy
21,320
+8,415
+65% +$735K 0.02% 282
2023
Q4
$1.24M Hold
12,905
0.01% 304
2023
Q3
$1.14M Sell
12,905
-163
-1% -$14.4K 0.01% 303
2023
Q2
$1.13M Sell
13,068
-24,215
-65% -$2.1M 0.01% 308
2023
Q1
$3.63M Sell
37,283
-426
-1% -$41.4K 0.04% 241
2022
Q4
$3.9M Sell
37,709
-74
-0.2% -$7.66K 0.05% 241
2022
Q3
$3.2M Buy
37,783
+20
+0.1% +$1.7K 0.04% 265
2022
Q2
$3.13M Buy
37,763
+1,134
+3% +$94K 0.04% 277
2022
Q1
$2.82M Buy
36,629
+26,434
+259% +$2.04M 0.03% 303
2021
Q4
$901K Buy
10,195
+197
+2% +$17.4K 0.01% 349
2021
Q3
$773K Sell
9,998
-57
-0.6% -$4.41K 0.01% 370
2021
Q2
$839K Sell
10,055
-110
-1% -$9.18K 0.01% 374
2021
Q1
$768K Sell
10,165
-166
-2% -$12.5K 0.01% 375
2020
Q4
$906K Buy
10,331
+20
+0.2% +$1.75K 0.01% 364
2020
Q3
$784K Sell
10,311
-101
-1% -$7.68K 0.01% 366
2020
Q2
$1.28M Sell
10,412
-34
-0.3% -$4.19K 0.02% 349
2020
Q1
$883K Sell
10,446
-3,261
-24% -$276K 0.01% 366
2019
Q4
$1.16M Sell
13,707
-5,868
-30% -$496K 0.01% 378
2019
Q3
$1.32M Sell
19,575
-25
-0.1% -$1.69K 0.01% 383
2019
Q2
$1.68M Sell
19,600
-97
-0.5% -$8.31K 0.02% 382
2019
Q1
$1.75M Buy
19,697
+53
+0.3% +$4.71K 0.02% 376
2018
Q4
$1.67M Buy
19,644
+5,772
+42% +$492K 0.02% 386
2018
Q3
$1.35M Sell
13,872
-36
-0.3% -$3.49K 0.01% 421
2018
Q2
$1.31M Sell
13,908
-40
-0.3% -$3.77K 0.01% 421
2018
Q1
$1.13M Buy
13,948
+4,269
+44% +$346K 0.01% 455
2017
Q4
$863K Buy
+9,679
New +$863K 0.01% 515
2015
Q3
Sell
-2,002
Closed -$274K 648
2015
Q2
$274K Buy
+2,002
New +$274K ﹤0.01% 634